A lifecycle approach to HIV prevention in African women and children

Current HIV/AIDS Reports

Volumn 11, Issue 2, 2014, Pages 119-127

  Roxby, Alison C ^a   Unger, Jennifer A ^b   Slyker, Jennifer A ^a   Kinuthia, John ^c   Lewis, Andrew ^a   John Stewart, Grace ^a,b   Walson, Judd L ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c KENYATTA NATIONAL HOSPITAL   (Kenya)

Author keywords

Adolescent health; Child health; Global epidemic; HIV; HIV prevention; Maternal health; Millennium development goals; Mother to child transmission of HIV; PMTCT

Indexed keywords

EMTRICITABINE; TENOFOVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT HEALTH; AFRICA SOUTH OF THE SAHARA; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; CHILD; CHILD HEALTH; CIRCUMCISION; CONTRACEPTION; EARLY CHILDHOOD INTERVENTION; EDUCATIONAL STATUS; FAMILY PLANNING; FEMALE; FIRST TRIMESTER PREGNANCY; HETEROSEXUALITY; HIV EDUCATION; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION PREVENTION; INFECTION RISK; LIFECYCLE APPROACH; MATERNAL MORTALITY; MATERNAL WELFARE; OUTCOME ASSESSMENT; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SURVIVAL; UNWANTED PREGNANCY; VIRUS TRANSMISSION; ADOLESCENT; CHILD HEALTH CARE; EPIDEMIOLOGY; FAMILY; HEALTH SERVICE; HIV INFECTIONS; INCIDENCE; INFANT; MALE; PREGNANCY; PRESCHOOL CHILD; PREVALENCE; PREVENTION AND CONTROL; TRANSMISSION; VERTICAL TRANSMISSION;

ADOLESCENT; ADOLESCENT HEALTH SERVICES; AFRICA SOUTH OF THE SAHARA; ANTI-HIV AGENTS; CHILD; CHILD HEALTH SERVICES; CHILD, PRESCHOOL; FAMILY; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MATERNAL HEALTH SERVICES; PREGNANCY; PREVALENCE;

EID: 84903598581     PISSN: 15483568     EISSN: 15483576     Source Type: Journal    
DOI: 10.1007/s11904-014-0203-2     Document Type: Review

References (66)

1. United Nations. United Nations millenium development goals report 2010. New York, NY; 2010.
2. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, et al. Prevention of HIV-1 infectionwith early antiretroviral therapy. N Engl J Med. 2011;365:493-505.
3. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367:399-410.
4. Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367:423-34.
5. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIVinfection in women. Science. 2010;329:1168-74.
6. Marrazzo JM, Ramjee G, Nair G, Palanee T, Mkhize B, et al. Preexposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir/ emtricitabine, or vaginal tenofovir gel in the VOICE study (MTN-003). 2013 Conference on Retroviruses and Opportunistic Infections. Atlanta, GA; 2013.
7. Abdool Karim Q, Kharsany AB, Frohlich JA, Werner L, Mlotshwa M, et al. HIV incidence in young girls in KwaZulu-Natal, South Africa-public health imperative for their inclusion in HIV biomedical intervention trials. AIDS Behav. 2012;16:1870-6.
8. Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367:411-22.
9. Friend DR, Kiser PF. Assessment of topicalmicrobicides to prevent HIV-1 transmission: concepts, testing, lessons learned. Antiviral Res. 2013;99:391-400.
10. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2:e298.
11. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369:643-56. (Pubitemid 46281312)
12. Gray RH, Kigozi G, Serwadda D, Makumbi F,Watya S, et al.Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369:657-66.
13. • Auvert B, Taljaard D, Rech D, Lissouba P, Singh B, et al. Association of the ANRS-12126 male circumcision project with HIV levels among men in a South African township: evaluation of effectiveness using cross-sectional surveys. PLoS Med. 2013;10: e1001509. Using population surveys in an area where circumcision was recently introduced, this study showed durable reductions in HIV prevalence among circumcised men and 19% lower HIV prevalence than would have been expected without the voluntary male circumcision program.
14. Centers for Disease Control and Prevention. Progress in voluntary medical male circumcision service provision - Kenya, 2008-2011. MMWR Morb Mortal Wkly Rep. 2012;61:957-61.
15. Kohler HP, Thornton R. Conditional cash transfers and HIV/AIDS prevention: unconditionally promising? World Bank Econ Rev. 2012;26:165-90.
16. Baird SJ, Garfein RS, McIntosh CT, Ozler B. Effect of a cash transfer programme for schooling on prevalence of HIVand herpes simplex type 2 in Malawi: a cluster randomised trial. Lancet. 2012;379:1320-9.
17. Pettifor A, MacPhail C, Nguyen N, Rosenberg M. Can money prevent the spread of HIV? A review of cash payments for HIV prevention. AIDS Behav. 2012;16:1729-38.
18. .• Heise L, Lutz B, Ranganathan M, Watts C. Cash transfers for HIV prevention: considering their potential. J Int AIDS Soc. 2013;16: 18615. This paper reviews the available evidence on conditional cash transfers and HIV prevention including recommendations for future research.
19. de Walque D, Dow WH, Nathan R, Abdul R, Abilahi F, et al. Incentivising safe sex: a randomised trial of conditional cash transfers for HIV and sexually transmitted infection prevention in rural Tanzania. BMJ Open. 2012;2:e000747.
20. Cowan F, Pettifor A. HIV in adolescents in sub-Saharan Africa. Curr Opin HIV AIDS. 2009;4:288-93.
21. Hardee K, Gay J, Croce-Galis M, Peltz A. Strengthening the enabling environment for women and girls: what is the evidence in social and structural approaches in the HIVresponse? J Int AIDS Soc. 2014;17:18619.
22. • World Health Organization. Programmatic update: Use of antiretroviral drugs for treating pregnant woman and preventing HIV infection in infants. 2012. This report outlines the rationale for Options B and B+ for prevention of mother-to-child transmission of HIV and describes the benefits to mothers, infants and partners.
23. Stringer EM, Ekouevi DK, Coetzee D, Tih PM, Creek TL, et al. Coverage of nevirapine-based services to prevent mother-to-child HIV transmission in 4 African countries. JAMA. 2010;304:293-302.
24. .• Sibanda EL, Weller IV, Hakim JG, Cowan FM. The magnitude of loss to follow-up of HIV-exposed infants along the prevention of mother-to-child HIV transmission continuum of care: a systematic review and meta-analysis. AIDS. 2013;27:2787-97. This review pools data from multiple published studies worldwide and shows that HIV-exposed children are highly unlikely to receive all services; based on their estimates, only 20% of infants are followed to a postnatal test.
25. Wettstein C, Mugglin C, Egger M, Blaser N, Vizcaya LS, et al. Missed opportunities to prevent mother-to-child-transmission: systematic review and meta-analysis. AIDS. 2012;26:2361-73.
26. Homsy J, Moore D, Barasa A, Were W, Likicho C, et al. Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-Infected women on highly active antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr. 2010;53:28-35.
27. Shapiro RL, Hughes MD, Ogwu A, Kitch D, Lockman S, et al. Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med. 2010;362:2282-94.
28. Mbori-Ngacha D, Nduati R, John G, ReillyM, Richardson B, et al. Morbidity and mortality in breastfed and formula-fed infants of HIV-1-infected women: a randomized clinical trial. JAMA. 2001;286:2413-20. (Pubitemid 33098159)
29. Thomas TK, Masaba R, Borkowf CB, Ndivo R, Zeh C, et al. Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding-the Kisumu Breastfeeding Study, Kenya: a clinical trial. PLoS Med. 2011;8:e1001015.
30. Watts DH, Brown ER, Maldonado Y, Herron C, Chipato T, et al. HIV disease progression in the first year after delivery among African women followed in the HPTN 046 clinical trial. J Acquir Immune Defic Syndr. 2013;64:299-306.
31. Centers for Disease Control and Prevention. Impact of an innovative approach to prevent mother-to-child transmission of HIV- Malawi, July 2011-September 2012. MMWR Morb Mortal Wkly Rep. 2013;62:148-51.
32. • Zaba B, Calvert C, Marston M, Isingo R, Nakiyingi-Miiro J, et al. Effect of HIV infection on pregnancy-related mortality in sub- Saharan Africa: secondary analyses of pooled community-based data from the network for Analysing Longitudinal Populationbased HIV/AIDS data on Africa (ALPHA). Lancet. 2013;381: 1763-71. Using pooled data from East and Southern Africa, this paper concluded that pregnant and postpartum HIV-infected women experience 8 times the mortality of uninfected women, and predicted that 24% of maternal death in Africa is attributable to HIV.
33. Moodley J, Pattinson RC, Baxter C, Sibeko S, Abdool Karim Q. Strengthening HIV services for pregnant women: an opportunity to reduce maternal mortality rates in Southern Africa/sub-Saharan Africa. BJOG. 2011;118:219-25.
34. World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for a public health approach. 2010 Version. Geneva; 2010.
35. UNAIDS. UNAIDS report on the global HIVepidemic; 2013.
36. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359:2233-44.
37. Zunza M, Mercer GD, Thabane L, Esser M, Cotton MF. Effects of postnatal interventions for the reduction of vertical HIV transmission on infant growth and non-HIV infections: a systematic review. J Int AIDS Soc. 2013;16:18865.
38. Braun M, Kabue MM, McCollum ED, Ahmed S, Kim M, et al. Inadequate coordination of maternal and infant HIV services detrimentally affects early infant diagnosis outcomes in Lilongwe, Malawi. J Acquir Immune Defic Syndr. 2011;56:e122-8.
39. Ciampa PJ, Burlison JR, Blevins M, Sidat M, Moon TD, et al. Improving retention in the early infant diagnosis of HIV programin rural Mozambique by better service integration. J Acquir Immune Defic Syndr. 2011;58:115-9.
40. Adebimpe WO. Challenges facing early infant diagnosis of HIV among infants in resource poor settings. Afr J Reprod Health. 2013;17:122-9.
41. Chi BH, Bolton-Moore C, Holmes CB. Prevention of mother-tochildHIV transmission within the continuum ofmaternal, newborn, and child health services. Curr Opin HIVAIDS. 2013;8:498-503.
42. Ghadrshenas A, Ben Amor Y, Chang J, Dale H, Sherman G, et al. Improved access to early infant diagnosis is a critical part of a childcentric prevention of mother-to-child transmission agenda. AIDS. 2013;27 Suppl 2:S197-205.
43. UNAIDS. AIDS by the numbers; 2013.
44. Nyberg BJ, Yates DD, Lovich R, Coulibaly-Traore D, Sherr L, et al. Saving lives for a lifetime: supporting orphans and vulnerable children impacted by HIV/AIDS. J Acquir Immune Defic Syndr. 2012;60 Suppl 3:S127-35.
45. Amoako Johnson F, Padmadas SS, Smith PW. Orphanhood and vulnerability: a conduit to poor child health outcomes in Rwanda. AIDS Care. 2010;22:314-23.
46. Kinuthia J, Kiarie JN, Farquhar C, Richardson B, Nduati R, et al. Cofactors for HIV-1 incidence during pregnancy and postpartum period. Curr HIV Res. 2010;8:510-4.
47. Moodley D, Esterhuizen T, Reddy L, Moodley P, Singh B, et al. Incident HIV infection in pregnant and lactating women and its effect on mother-to-child transmission in South Africa. J Infect Dis. 2011;203:1231-4.
48. Theron GB, Shapiro DE, Van Dyke R, Cababasay MP, Louw J, et al. Rapid intrapartum or postpartum HIV testing at a midwife obstetric unit and a district hospital in South Africa. Int J Gynaecol Obstet. 2011;113:44-9.
49. Humphrey JH, Marinda E, Mutasa K, Moulton LH, Iliff PJ, et al. Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: prospective cohort study. BMJ. 2010;341:c6580.
50. Alkema L, Kantorova V, Menozzi C, Biddlecom A. National, regional, and global rates and trends in contraceptive prevalence and unmet need for family planning between 1990 and 2015: a systematic and comprehensive analysis. Lancet. 2013;381:1642-52.
51. .• Darroch JE, Singh S. Trends in contraceptive need and use in developing countries in 2003, 2008, and 2012: an analysis of national surveys. Lancet. 2013;381:1756-62. This review analyzes national data on contraceptive use in 2003, 2008 and 2012 including both married and unmarried women, and concludes ongoing high unmet need for contraception, especially in sub-Saharan Africa.
52. Heffron R, DonnellD, Rees H, CelumC,Mugo N, et al. (2011)Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis.
53. Polis CB, Phillips SJ, Curtis KM. Hormonal contraceptive use and female-to-male HIV transmission: a systematic review of the epidemiologic evidence. AIDS. 2013;27:493-505.
54. Polis CB, Curtis KM. Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. Lancet Infect Dis. 2013;13:797-808.
55. Stuart GS. Fourteen million women with limited options: HIV/ AIDS and highly effective reversible contraception in sub- Saharan Africa. Contraception. 2009;80:412-6.
56. Peltzer K, Chao LW, Dana P. Family planning among HIV positive and negative prevention of mother to child transmission (PMTCT) clients in a resource poor setting in South Africa. AIDS Behav. 2009;13:973-9.
57. Jhangri GS, Heys J, Alibhai A, Rubaale T, KippW. Unmet need for effective family planning inHIV-infected individuals: results froma survey in rural Uganda. J Fam Plann Reprod Health Care. 2012;38:23-9.
58. Leslie JA, Munyambanza E, Adamchak SE, Janowitz B, Grey TW, et al. Without strong integration of family planning into PMTCT services in Rwanda, clients remain with a high unmet need for effective family planning. Afr J Reprod Health. 2010;14:144-6.
59. Harrington EK, Newmann SJ, Onono M, Schwartz KD, Bukusi EA, et al. Fertility intentions and interest in integrated family planning services among women living with HIV in Nyanza Province, Kenya: a qualitative study. Infect Dis Obstet Gynecol. 2012;2012:809682.
60. Schwartz SR, Rees H, Mehta S, Venter WD, Taha TE, et al. High incidence of unplanned pregnancy after antiretroviral therapy initiation: findings from a prospective cohort study in South Africa. PLoS One. 2012;7:e36039.
61. Wilcher R, Hoke T, Adamchak SE, Cates Jr W. Integration of family planning into HIV services: a synthesis of recent evidence. AIDS. 2013;27 Suppl 1:S65-75.
62. Wilcher R, Petruney T, Cates W. The role of family planning in elimination of new pediatric HIV infection. Curr Opin HIVAIDS. 2013;8:490-7.
63. Chang LW, Serwadda D, Quinn TC, Wawer MJ, Gray RH, et al. Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effects. Lancet Infect Dis. 2013;13:65-76.
64. Vermund SH, Hayes RJ. Combination prevention: new hope for stopping the epidemic. Curr HIV/AIDS Rep. 2013;10:169-86.
65. Alsallaq RA, Baeten JM, Celum CL, Hughes JP, Abu-Raddad LJ, et al. Understanding the potential impact of a combination HIV prevention intervention in a hyper-endemic community. PLoS One. 2013;8:e54575.
66. Gounder CR, Chaisson RE. A diagonal approach to building primary healthcare systems in resource-limited settings: women-centred integration of HIV/AIDS, tuberculosis, malaria, MCH and NCD initiatives. Trop Med Int Health. 2012;17: 1426-31.